THC’s effects in HIV mice vary by sex and brain pathway
Chronic THC exposure modulates behavioral outcomes and endocannabinoid signaling in HIV-1 Tg26 mice in a sex-dependent manner.
AI Summary
This mouse study examined how chronic Δ9-tetrahydrocannabinol (THC) affects brain and spinal-cord function in the presence of HIV-1 viral proteins. HIV-1 expression was linked to impaired cerebellum-dependent motor learning, particularly in females, alongside increased monoacylglycerol lipase and reduced 2-arachidonoylglycerol (2-AG)—changes suggesting disrupted endocannabinoid signaling. In males, higher cerebellar CB1 and CB2 receptor expression was associated with preserved performance on a motor- coordination task.
In the spinal cord, HIV-1 expression was associated with reduced thermal sensitivity and lower levels of 2-AG and cannabinoid receptors. Chronic THC did not produce a detectable pain-relieving effect in this model, but it did lessen the decline in motor coordination over time while increasing cerebellar CB1 receptor expression. The findings come from mice and do not establish how cannabis affects people living with HIV, but they suggest that sex-specific biology and altered endocannabinoid signaling may influence cannabinoid responses in the context of chronic HIV-related brain injury.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Small lab study finds cannabis affected simulated driving and confidence
A lab method measures 17 cannabinoids across five hemp product types
A single-center study finds varied care and no recurrence in follow-up
Explore More Research
Stay informed about the latest cannabis science.